The General Hospital Corporation Research Management Division, doing business as Massachusetts General Hospital (MGH), received a $256,296 Project Grant award from the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867). The award aims to develop and validate new adaptive ranging optical coherence tomography angiography (OCTA) technology to improve the imaging of critical peripheral retinal microvasculature. This will support the diagnosis and management of vision-threatening diseases such as diabetic retinopathy, glaucoma, macular degeneration, and retinal vein occlusion. The award period is from February 1, 2025 to January 31, 2027. If successful, this work could enhance clinicians' ability to image and evaluate the peripheral retinal microvasculature, which may lead to improved detection and treatment of multiple eye diseases.
Generated 2/25/25, 3:02 AM